المؤلفون: Chocarro, Luisa, Bocanegra, Ana, Blanco, Ester, Fernández-Rubio, Leticia, Arasanz, Hugo, Echaide, Miriam, Garnica, Maider, Ramos, Pablo, Piñeiro-Hermida, Sergio, Vera, Ruth, Escors, David, Kochan, Grazyna, orcid:0000-0002-3508-0595, orcid:0000-0002-2980-7137, orcid:0000-0001-6838-6702, orcid:0000-0002-7371-1626, orcid:0000-0003-2828-4458

مصطلحات موضوعية: BMS-986016, LAG-3, nivolumab, opdualag, PD-1, relatimab

وصف الملف: application/pdf

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35954196; info:eu-repo/semantics/altIdentifier/eissn/2073-4409; Cutting-Edge: Preclinical and Clinical Development of the First Approved Lag-3 Inhibitor, 2022, vol. 11, núm. 15; https://investigacion.unirioja.es/documentos/63138b62b8384f133e2d371cTest; urn:issn:2073-4409

الإتاحة: https://doi.org/10.3390/CELLS11152351Test
https://investigacion.unirioja.es/documentos/63138b62b8384f133e2d371cTest

المؤلفون: Adili, Ali, Ghoreishizadeh, Shadi, Shomali, Navid, Hasani, Sadegh Abaei, Sharafi, Faezeh, Alesaeidi, Samira, Kahrizi, Mohammad Saeed

مصطلحات موضوعية: Hepatocellular carcinoma, T-Cells, Blockade, Ctla-4, Immune checkpoint inhibitors, Combination therapy, Acquired-Resistance, Tigit, Antitumor, Tim-3, Lag-3, Tremelimumab, Mechanisms

العلاقة: Cancer Cell International; Diğer; https://hdl.handle.net/11454/77817Test; https://doi.org/10.1186/s12935-022-02682-zTest; Kahrizi, Mohammad saeed/0000-0002-8076-2413; 22

الإتاحة: https://doi.org/10.1186/s12935-022-02682-zTest
https://hdl.handle.net/11454/77817Test

المؤلفون: Sharafi, Faezeh, Hasani, Sadegh Abaei, Alesaeidi, Samira, Kahrizi, Mohammad Saeed, Adili, Ali, Ghoreishizadeh, Shadi, Shomali, Navid

مصطلحات موضوعية: Immune checkpoint inhibitors, Hepatocellular carcinoma, Combination therapy, Acquired-Resistance, T-Cells, Blockade, Ctla-4, Tigit, Antitumor, Tim-3, Lag-3, Tremelimumab, Mechanisms

العلاقة: Cancer Cell International; Diğer; https://doi.org/10.1186/s12935-022-02682-zTest; https://hdl.handle.net/11454/85121Test; 22; WOS:000843527300004; 2-s2.0-85136994397

الإتاحة: https://doi.org/10.1186/s12935-022-02682-zTest
https://hdl.handle.net/11454/85121Test

المؤلفون: Sharafi, Faezeh, Hasani, Sadegh Abaei, Alesaeidi, Samira, Kahrizi, Mohammad Saeed, Adili, Ali, Ghoreishizadeh, Shadi, Shomali, Navid

مصطلحات موضوعية: Immune checkpoint inhibitors, Hepatocellular carcinoma, Combination therapy, Acquired-Resistance, T-Cells, Blockade, Ctla-4, Tigit, Antitumor, Tim-3, Lag-3, Tremelimumab, Mechanisms

العلاقة: Cancer Cell International; Diğer; https://doi.org/10.1186/s12935-022-02682-zTest; https://hdl.handle.net/11454/77817Test; 22; WOS:000843527300004; 2-s2.0-85136994397

الإتاحة: https://doi.org/10.1186/s12935-022-02682-zTest
https://hdl.handle.net/11454/77817Test

المؤلفون: Dulal, Dharmindra, Boring, Andrew, Terrero, David, Johnson, Tiffany, Tiwari, Amit K, Raman, Dayanidhi

المصدر: Cancers (Basel) ; ISSN:2072-6694 ; Volume:15 ; Issue:10

مصطلحات موضوعية: CD8+ T lymphocytes, CTLA-4, LAG-3, PD-1, TIGIT, TIM-3, VISTA, immune checkpoints, immuno-refractory tumors, immunosuppression, immunotherapy

العلاقة: https://doi.org/10.3390/cancers15102774Test; https://pubmed.ncbi.nlm.nih.gov/37345111Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216651Test/

الإتاحة: https://doi.org/10.3390/cancers15102774Test
https://pubmed.ncbi.nlm.nih.gov/37345111Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216651Test/

المؤلفون: Raval, Raju R, Sharabi, Andrew B, Walker, Amanda J, Drake, Charles G, Sharma, Padmanee

مصطلحات موضوعية: CTLA-4, PD-1, Melanoma, Prostate cancer, Kidney cancer, Bladder cancer, PD-L1, LAG-3

العلاقة: http://www.immunotherapyofcancer.org/content/2/1/14Test

الإتاحة: http://www.immunotherapyofcancer.org/content/2/1/14Test

المؤلفون: Larsson, Marie, Shankar, Esaki M, Che, Karlhans F, Saeidi, Alireza, Ellegård, Rada, Barathan, Muttiah, Velu, Vijayakumar, Kamarulzaman, Adeeba

مصطلحات موضوعية: BLIMP-1, CTLA-4, FoxP3, HIV-1, T-cell inhibition, LAG-3, PD-1, TIM-3, 2B4, CD160

العلاقة: http://www.retrovirology.com/content/10/1/31Test

الإتاحة: http://www.retrovirology.com/content/10/1/31Test